These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 21735688

  • 1. [Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate].
    Milewicz T, Krzysiek J, Rogatko I, Sztefko K, Stochmal E, Hubalewska-Dydejczyk A, Jach R, Radowicki S.
    Ginekol Pol; 2011 Mar; 82(3):200-4. PubMed ID: 21735688
    [Abstract] [Full Text] [Related]

  • 2. Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study.
    Helle SI, Omsjø IH, Hughes SC, Botta L, Hüls G, Holly JM, Lønning PE.
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):727-32. PubMed ID: 9039339
    [Abstract] [Full Text] [Related]

  • 3. The insulin-like growth factor-I system and hormone replacement therapy.
    Cardim HJ, Lopes CM, Giannella-Neto D, da Fonseca AM, Pinotti JA.
    Fertil Steril; 2001 Feb; 75(2):282-7. PubMed ID: 11172828
    [Abstract] [Full Text] [Related]

  • 4. The somatotropic axis in postmenopausal women during six month of transdermal continuous 17beta-estradiol administration combined with oral medroxyprogesterone.
    Milewicz T, Krzysiek J, Rogatko I, Sztefko K, Stochmal E, Hubalewska-Dydejczyk A, Jach R, Radowicki S.
    Ginekol Pol; 2011 Apr; 82(4):254-8. PubMed ID: 21721462
    [Abstract] [Full Text] [Related]

  • 5. 17beta-estradiol regulation of human growth hormone (hGH), insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) axis in hypoestrogenic, hypergonadotropic women.
    Milewicz T, Krzysiek J, Sztefko K, Radowicki S, Krzyczkowska-Sendrakowska M.
    Endokrynol Pol; 2005 Apr; 56(6):876-82. PubMed ID: 16821205
    [Abstract] [Full Text] [Related]

  • 6. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 7. Plasma insulin-like growth factor-I and its binding proteins 1 and 3 during continuous nonoral and oral combined hormone replacement therapy.
    Raudaskoski T, Knip M, Laatikainen T.
    Menopause; 1998 Mar; 5(4):217-22. PubMed ID: 9872487
    [Abstract] [Full Text] [Related]

  • 8. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Mar; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 9. Modification of serum IGF-I, IGFBPs and SHBG levels by different HRT regimens.
    Biglia N, Ambroggio S, Ponzone R, Sgro L, Ujcic E, Dato FA, Sismondi P.
    Maturitas; 2003 Aug 20; 45(4):283-91. PubMed ID: 12927315
    [Abstract] [Full Text] [Related]

  • 10. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug 20; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 11. Effect of menopause and different combined estradiol-progestin regimens on basal and growth hormone-releasing hormone-stimulated serum growth hormone, insulin-like growth factor-1, insulin-like growth factor binding protein (IGFBP)-1, and IGFBP-3 levels.
    Cano A, Castelo-Branco C, Tarín JJ.
    Fertil Steril; 1999 Feb 20; 71(2):261-7. PubMed ID: 9988395
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels.
    Paassilta M, Karjalainen A, Kervinen K, Savolainen MJ, Heikkinen J, Bäckström AC, Kesäniemi YA.
    Atherosclerosis; 2000 Mar 20; 149(1):157-62. PubMed ID: 10704627
    [Abstract] [Full Text] [Related]

  • 13. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.
    Maturitas; 2002 Apr 25; 41(4):299-311. PubMed ID: 12034517
    [Abstract] [Full Text] [Related]

  • 14. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E, Lacut K, Roudaut N, Mottier D, Kerlan V, Oger E.
    Clin Endocrinol (Oxf); 2007 May 25; 66(5):626-31. PubMed ID: 17492948
    [Abstract] [Full Text] [Related]

  • 15. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY, Leung KC, Baxter RC, Ho KK.
    J Clin Endocrinol Metab; 2000 May 25; 85(5):1918-22. PubMed ID: 10843175
    [Abstract] [Full Text] [Related]

  • 16. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
    Kurtay G, Ozmen B, Erguder I.
    Maturitas; 2006 Jan 10; 53(1):32-8. PubMed ID: 16325022
    [Abstract] [Full Text] [Related]

  • 17. Oral 17beta-estradiol and sequential progesterone in menopause: effects on insulin-like growth factors and their binding proteins.
    Mozzanega B, Babbo GL, Salmaso L, De Toni R, Schiavo A, Mioni R, de Kreutzenberg SV.
    Gynecol Endocrinol; 2007 Jan 10; 23(1):50-7. PubMed ID: 17484513
    [Abstract] [Full Text] [Related]

  • 18. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 10; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 19. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women.
    Garnero P, Tsouderos Y, Marton I, Pelissier C, Varin C, Delmas PD.
    J Clin Endocrinol Metab; 1999 Jul 10; 84(7):2390-7. PubMed ID: 10404809
    [Abstract] [Full Text] [Related]

  • 20. Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial.
    Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR.
    Cancer Epidemiol Biomarkers Prev; 2003 Aug 10; 12(8):721-7. PubMed ID: 12917202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.